Arcutis Biotherapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Arcutis Biotherapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2023.
  • Arcutis Biotherapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $241K, a 36.9% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Operating Lease, Payments for 2023 was $965K, a 23.6% increase from 2022.
  • Arcutis Biotherapeutics, Inc. annual Operating Lease, Payments for 2022 was $781K, a 585% increase from 2021.
  • Arcutis Biotherapeutics, Inc. annual Operating Lease, Payments for 2021 was $114K, a 40.6% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $241K +$65K +36.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q1 2022 $176K +$176K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $0 -$47K -100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $47K +$31K +194% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $16K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.